How to buy CME Group shares

CME Group shares have fallen -0.20% from yesterday's closing price ($176.67). Learn how to easily invest in CME Group shares in the UK.

CME Group Inc
NASDAQ: CME - USD
$176.67
- $0.35 ( - 0.20%)
FINANCIAL DATA & STOCK EXCHANGES

CME Group Inc (CME) is a publicly traded financial data and stock exchanges business based in the US. It opened the day at $176.7 after a previous close of $177.02. During the day the price has varied from a low of $176.4 to a high of $177.85. The latest price was $176.67 (25 minute delay). CME Group is listed on the NASDAQ and employs 3,460 staff. All prices are listed in US Dollars.

How to buy shares in CME Group

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: CME in this case.
  5. Research CME Group shares. The platform should provide the latest information available.
  6. Buy your CME Group shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.
Our top picks for where to buy CME Group shares:

Best for

Beginner investments

IG Share Dealing image

Fees for buying 5x CME Group shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Customer rating Platform fee Min. initial deposit Trading fee estimate
Freetrade logo ★★★★★ £0 - £9.99 No minimum £4.22
£719.56 total
Capital at risk
eToro Free Stocks logo ★★★★★ £0 $50 £3.58
£718.91 total
Capital at risk
IG Share Dealing logo ★★★★★ £0 £250 £11.72
£727.05 total
Capital at risk
CMC Invest share dealing account logo Not yet rated £0 No minimum £3.58
£718.91 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo ★★★★★ £0 £1 £19.10
£734.44 total
Capital at risk
Degiro Share Dealing logo ★★★★★ £0 No minimum £0.72
£716.05 total
Capital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Alternative ways to invest in CME Group

Is it a good time to buy CME Group stock?

Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks

Invest in CME Group shares

  • Start investing from $50
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is CME Group under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the CME Group P/E ratio, PEG ratio and EBITDA

CME Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, CME Group shares trade at around 22x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

CME Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.6929. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CME Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

CME Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $3.4 billion (£2.8 billion).

The EBITDA is a measure of a CME Group's overall financial performance and is widely used to measure a its profitability.

What's CME Group's ESG track record?

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CME Group.

Overall CME Group ESG score

CME Group's total ESG risk: 16.2

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CME Group's overall score of 16.2 (as at 12/31/2018) is excellent – landing it in it in the 10th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like CME Group is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

CME Group's environmental score: 6.41/100

CME Group's environmental score of 6.41 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

CME Group's social score: 9.64/100

CME Group's social score of 9.64 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CME Group is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

CME Group's governance score: 8.65/100

CME Group's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that CME Group is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

CME Group's controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, CME Group scored a 1 out of 5 for controversy – the highest score possible, reflecting that CME Group has managed to keep its nose clean.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site